INFANT VACCINE  ~

Actively Seeking healthy infants (age 6 to 12 weeks old) to participate in a safety study of 2 formulations of GKS’s human rotavirus (HRV) vaccine.

URINARY STRESS INCONTINENCE (SUIs)

Actively seeking women, pre-menopausal, 18-50 years of age, who experience stress incontinence for a non-invasive investigational treatment.

ASTHMA  ~

Actively seeking individuals, 4 years if age and older, to assist in evaluating the effectiveness and safety of a study drug administered as needed in response to symptoms in symptomatic adults and children with Asthma. Qualifying patients will have needed to have had a severe exacerbation within the past year.

ATOPIC DERMATITIS  ~

Actively seeking pediatric and adult participants, who have mild-to-moderate atopic dermatitis, to evaluate the long-term maintenance treatment and flare reduction with Crisaborole Ointment 2%.

 

DIABETES & CHRONIC KIDNEY DISEASE  ~

Actively seeking individuals, 18 years or older, to participate in a research study to look at how well Semaglutide works when compared to the ‘dummy medicine’ in slowing the growth and worsening of diabetic kidney disease in those with Type 2 Diabetes.

OSTEOARTHRITIS OF THE KNEE ~

Actively seeking individuals, 18 years or older, to participate in a research study to assess the effectiveness and safety of a 14-day dosing regimen of 3 doses of a naproxen derivative (investigational medication) versus placebo, orally administered once daily to male and females with osteoarthritis of the knee.

STATIN INTOLERANCE  ~

To assess the effects of Bempedoic Acid on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant.

 

RSV VACCINE  ~

Evaluating the safety, reactogenicity and immunogenicity of a single dose of an investigational RSV maternal vaccine when given along or in co-administration with a single dose of Boostrix in healthy, non-pregnant women 18-45 years of age.   RSV = Respiratory Syncytial Virus

VACCINE STUDY  ~

To test the safety of an investigational pneumonia vaccine, to see how well the vaccine works, and to see how the body handles the vaccine.

Type II DIABETES  ~

Assessing the effectiveness and safety of Semaglutide 2.0mg once-weekly injection compared to Semaglutide 1.0mg once-weekly injection in patients with T2DM as an add-on therapy.

DIABETES & OBESITY  ~

Studying the effect and safety of an investigational medication on patients with obesity and Type II Diabetes.

 

DIABETES & CVD  ~

Observing the effect of study medication on patients with Type II Diabetes and high cardiovascular disease or risks.

 

DIABETES  ~

Comparing the effectiveness and safety of an investigational once-weekly drug versus Semaglutide as an add-on therapy to metformin in patients with Type II Diabetes.

Contact us at 519.659.4040 to find out more about participating in a study.

Why participate in a study?

Benefits to joining a clinical research study :

  • you may be able to help others by providing a better understanding of a medical condition and how it is treated in the future.
  • you may receive medications which are not available otherwise.
  • you may learn more about your medical condition.

Visit the joinastudy.ca website, to find out more about how clinical research studies work.